• Reagents
    • Overview
    • Nanocin PLASMID
    • Nanocin RNA
    • Nanocin PRO
    • Nanocin SM
  • Human Health
  • Animal Health
  • Drug Formulation
  • Bioprocessing
  • Support
    • Ask a Tecrea Scientist
    • FAQs
  • Buy
  • About
    • Company Information
    • Meet the team
    • Testimonials
    • Latest news
  • Contact
0 Items
  • Reagents
    • Overview
    • Nanocin PLASMID
    • Nanocin RNA
    • Nanocin PRO
    • Nanocin SM
  • Human Health
  • Animal Health
  • Drug Formulation
  • Bioprocessing
  • Support
    • Ask a Tecrea Scientist
    • FAQs
  • Buy
  • About
    • Company Information
    • Meet the team
    • Testimonials
    • Latest news
  • Contact
SOFI 2 South African Partners Visit the UK for Collaborative Initiatives

SOFI 2 South African Partners Visit the UK for Collaborative Initiatives

by admin | Nov 11, 2024 | Uncategorized

Tecrea Ltd. is working alongside a South African-based company as part of the Scaling Out for Impact (SOFI 2) program, aimed at advancing UK-South Africa innovation partnerships. This program seeks to accelerate the development and implementation of affordable,...

Recent Posts

  • Tecrea Ltd has been selected for the second cohort of the Accelerating FemTech programme
  • SOFI 2 South African Partners Visit the UK for Collaborative Initiatives
  • Tecrea Ltd. Awarded Innovate UK Funding
  • Successful Phase 2b human clinical trial result involving Tecrea’s Nanocin technology
  • Tecrea Announces Successful Completion of NBIC Flexible Talent Mobility Accounts Award Project
  • Follow
  • Follow

Need Assistance?

Contact Us

Products & Resources

Reagent Products

Bioprocessing

Drug Formulation

Support

About Tecrea

Company Info

Sustainability

Latest News

Quality Policy

Terms and Conditions | Privacy & Cookie Policy | Terms & Conditions of Sale

©2024 Tecrea Ltd.